Plus it is virtually a risk free investment by TAUG
Do you understand when $480,000 plummets to $0 that is a $480,000 loss? In the biopharma testing world there are no guarantees and a "guarantee" is the only way the VTGN holding could be deemed "risk free"! THE PAID CONSULTANT'S TOUTING BS NEVER CEASES!
BTW...good to see TAUG's PAID CONSULTANT is now acknowledging his earlier post claiming VTGN expects "Phase 2A results in the first half of 2018" was actually completely contrary to VTGN's published schedule!
When NIH release results this year...
As I stated..."this year" or "2nd half" means "before December 31, 2018"! Will the actual results be released in 2019? If there is a "slip", the results will certainly not be known until the first half of 2019 at the earliest! No "results" are going to be announced, as claimed by the PAID CONSULTANT, "in the first half of 2018"!
BTW...TAUG HAS UNTIL NOVEMBER 29, 2018 TO RESOLVE ITS "INVESTMENT COMPANY" PROBLEM! WILL TAUG BE FORCED TO DIVEST EQUITY ASSETS FOR A LOSS?
News 
Market Data 
Discover 
